Global Rotavirus Prophylaxis Market Overview
The rotavirus vaccine protects against rotavirus infections, which are the most common cause of severe diarrhoea in young children. Severe diarrhoea, vomiting, fever, and abdominal pain are all symptoms of rotavirus infection, which can lead to illness. The rotavirus vaccine is given orally in two or three doses beginning around the age of six weeks. Rotavirus is a Reoviridae virus with a double-stranded RNA genome that is transmitted by the faecal-oral route. It causes gastroenteritis by infecting the cell lining of the small intestine. Rotavirus sickness was a substantial health issue among children in both industrialized and developing countries prior to the arrival of rotavirus vaccines on the market.
Impact of Covid-19 pandemic on market
Clinical research battled with how to best keep participants safe from a new infectious disease as COVID-19 spread around the globe. The global health community has learnt what works to reduce COVID-19 risk during the last year, and new vaccines are progressively becoming available to countries to prevent COVID-19.
Global Rotavirus Prophylaxis Market Dynamics
Growth in business operations by emerging and small sized players
The rising frequency of rotavirus infection among children is a primary driver of the market, since it increases demand for rotavirus vaccines. The high frequency of rotavirus, as well as increased patient awareness and government initiatives, are driving the worldwide rotavirus prophylaxis market. Furthermore, advancements in the pharmaceutical and biotechnology sectors or industries, as well as an increase in vaccination demand, are some of the driving reasons for market expansion. Nonetheless, restricted income prospects, high treatment costs, and the scientific challenge of creating vaccines are some of the major challenges limiting the market's growth.
Global Rotavirus Prophylaxis Market Segmentation
Source: Prophecy Market Insights
The global Rotavirus prophylaxis market is segmented based on treatment, route of administration, end-user, and region.
On the basis of Treatment, the global Rotavirus prophylaxis market is segmented into Rotavac, Rotarix, Rotavin-M1 and Others. Based on Route of administration, the target market is segmented into Oral, Parenteral and Others. On the basis of End-user, the target market is segmented into Hospital, Homecare, Specialty centers and Others.
Regional Insights:
On region the global Rotavirus Prophylaxis Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold the largest market share for global rotavirus prophylaxis market. This is mainly because of the established regulatory framework, strong demand for disease-specific therapy, refined healthcare infrastructure, and greater patient awareness, as well as the high prevalence of rotavirus. Because of the existence of worldwide marketed players and the increase in population, Europe is considered the second fastest growing regional segment.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Treatment- Rotavac, Rotarix, Rotavin-M1 and Others By Route of administration–Oral, Parenteral and Others By End-user– Hospital, Homecare, Specialty centers and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Rotavirus prophylaxis market report based on treatment, route of administration, end-user, and region.
Global Rotavirus Prophylaxis Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Rotavirus Prophylaxis Market Key Players
The key players operating in the global Rotavirus prophylaxis market includes Lanzhou Institute of Biologicals Products Co., Ltd, QIMR Berghofer Medical Research Institute, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc, Sanofi and Others.
Global Rotavirus Prophylaxis Market Company Profile
- GlaxoSmithKline Plc,.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lanzhou Institute of Biologicals Products Co., Ltd
- QIMR Berghofer Medical Research Institute
- BIOVIRx Inc.
- Serum Institute of India Pvt. Ltd.
- Merck & Co., Inc.
- Bharat Biotech
- Sanofi
- Others.
“*” marked represents similar segmentation in other categories in the respective section
Global Rotavirus Prophylaxis Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Rotavirus Prophylaxis Strategies
- Key Questions this Study will Answer
- Market Snippet, By Treatment
- Market Snippet, By Route of administration
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Rotavirus Prophylaxis Market, By Treatment, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Rotavac
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Rotarix
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Rotavin-M1
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Rotavirus Prophylaxis Market, By Route of administration, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Oral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Parenteral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Rotavirus Prophylaxis Market, By End-user, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Homecare
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Specialty centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Rotavirus Prophylaxis Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Route of administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Route of administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Route of administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Route of administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Route of administration, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- GlaxoSmithKline Plc,.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Lanzhou Institute of Biologicals Products Co., Ltd
- QIMR Berghofer Medical Research Institute
- BIOVIRx Inc.
- Serum Institute of India Pvt. Ltd.
- Merck & Co., Inc.
- Bharat Biotech
- Sanofi
- Others.
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The global Rotavirus prophylaxis market is segmented based on treatment, route of administration, end-user, and region.
The high frequency of rotavirus, as well as increased patient awareness and government initiatives, are driving the worldwide rotavirus prophylaxis market.
North America is estimated to hold the largest market share for global rotavirus prophylaxis market. This is mainly because of the established regulatory framework, strong demand for disease-specific therapy, refined healthcare infrastructure, and greater patient awareness, as well as the high prevalence of rotavirus.
Companies are continuously rising the production and collaborating with each other, which is expected to drive the global rotavirus prophylaxis market.